For the latest on Thailand Medical Industry, Thailand Doctors, Thailand Medical Research, Thailand Hospitals, Thailand Wellness Initiatives and the latest Medical News

✖
BREAKING NEWS
Nikhil Prasad  Fact checked by:Thailand Medical News Team Nov 22, 2026  19 minutes ago

Major COVID-19 Vaccine Study by Crick Institute Retracted After Scientist Admits Fabricating Data and Committing Fraud

14710 Shares
facebook sharing button Share
twitter sharing button Tweet
linkedin sharing button Share
Major COVID-19 Vaccine Study by Crick Institute Retracted After Scientist Admits Fabricating Data and Committing Fraud
Nikhil Prasad  Fact checked by:Thailand Medical News Team Nov 22, 2026  19 minutes ago
A major scientific controversy has emerged over research into next-generation COVID-19 vaccines after a widely cited study from Britain's Francis Crick Institute was retracted following the discovery of fabricated experimental data and falsified scientific images. The study, which explored a potentially important strategy for developing vaccines capable of protecting against multiple coronavirus variants, had attracted international attention before investigators uncovered serious problems with its scientific integrity.


A widely cited experimental COVID-19 vaccine study from Britain's Francis Crick Institute has been retracted after investigators uncovered fabricated data and falsified scientific images, raising concerns about research integrity while leaving the broader science of S2-targeted coronavirus vaccines intact
 
The journal Science Translational Medicine formally retracted the July 2022 paper on October 14, 2026, after an institutional investigation identified former doctoral researcher Kevin W. Ng as responsible for the misconduct. Ng subsequently acknowledged responsibility for the fabrication, according to the journal's retraction notice.
 
The development has raised concerns about the reliability of published biomedical research, particularly studies investigating promising approaches to broader coronavirus immunity.
 
A Promising Vaccine Study That Attracted Global Attention
The retracted research, titled SARS-CoV-2 S2-targeted vaccination elicits broadly neutralizing antibodies, investigated whether directing immune responses toward a relatively stable portion of the coronavirus spike protein could provide protection against different SARS-CoV-2 variants.
 
Unlike conventional vaccine approaches primarily designed around the complete spike protein or its receptor-binding region, the experimental strategy focused on the S2 subunit.
 
Scientists have long considered S2 an attractive vaccine target because portions of this protein region are relatively conserved across different coronaviruses.
 
The original study used mice to examine whether an experimental DNA vaccine targeting S2 could stimulate antibodies capable of recognizing and neutralizing multiple coronaviruses.
 
The researchers reported promising antibody responses and evidence suggesting protection against SARS-CoV-2 challenge.
 
However, those findings can no longer be treated as reliable evidence following the retraction.
 
According to available citation records, the paper accumulated approximately 83 to 85 citations, depending on the database and reporting date. Other reports indicated approximately 37,000 downloads, demonstrating its substantial scientific reach.
 
Investigators Discover Fabricated Data and Falsified Images
The investigation conducted by the Francis Crick Institute uncovered serious irregularities involving experimental results and scientific figures.
 
According to the retraction notice, Ng was responsible for fabricated data in one figure and falsified images in another. Additional reporting described concerns involving three figures. />  
The findings were particularly troubling because scientific images and experimental datasets are essential for establishing whether biological mechanisms behave as researchers claim.
 
Manipulating such evidence can create misleading impressions about antibody responses, experimental reproducibility, or vaccine effectiveness.
 
More importantly, investigators found that some other experiments could not be independently verified because their original datasets and biological samples were unavailable.
 
This Thailand Medical News report highlights that the journal's concerns extended beyond the specific manipulated figures because missing primary evidence prevented retrospective verification of additional findings.
 
Consequently, the journal determined that retracting the entire article was necessary to protect the scientific record.
 
The retraction does not establish that every experiment was fabricated. Nevertheless, the documented misconduct and inability to verify other results made the publication scientifically unreliable.
 
Understanding Why the S2 Vaccine Strategy Matters
The scientific concept underlying the study remains important despite the misconduct.
 
The SARS-CoV-2 spike protein contains two major functional subunits, S1 and S2.
S1 contains the receptor-binding domain that helps the virus attach to human cells through the ACE2 receptor.
 
Many mutations associated with immune escape occur within S1, particularly around its receptor-binding domain.
 
These changes can reduce the ability of antibodies generated through vaccination or previous infection to recognize newer viral variants.
 
S2 performs a different function.
It participates in the membrane-fusion process that allows the virus to enter host cells after receptor engagement.
 
Because this machinery performs essential biological functions, significant portions of S2 are more conserved than the highly variable regions of S1.
 
Researchers therefore hope that vaccines targeting conserved S2 structures could generate antibodies recognizing multiple SARS-CoV-2 variants and potentially other related coronaviruses.
 
However, generating sufficiently powerful neutralizing antibodies against S2 remains challenging.
 
Conserved protein regions are not automatically accessible to antibodies, and immune responses against them may be weaker than responses against more immunodominant regions.
 
These difficulties explain why carefully validated experimental findings are particularly important.
 
What the Retracted Mouse Experiments Claimed to Demonstrate
The original research investigated whether S2-directed vaccination could produce broader antibody recognition than approaches focusing on more variable spike regions.
 
Its reported findings included antibody responses against multiple coronaviruses and indications of protection when vaccinated mice were challenged with SARS-CoV-2.
 
Such observations, if independently reproduced, could have supported further development of broader coronavirus vaccines.
 
Nevertheless, animal experiments represent an early stage of vaccine development.
 
Even reliable results in mice cannot establish that an experimental vaccine will provide effective protection in humans.
 
Human immune responses, antibody durability, vaccine safety, and protection against severe disease require additional investigation.
 
Because the paper has been retracted, its reported experimental outcomes should not be used to establish that the particular vaccine formulation was effective.
 
Second Major Retraction Involving the Same Researcher
The vaccine paper represents Ng's second major research retraction during 2026. In January, Nature retracted another publication involving Ng after an investigation identified manipulated experimental data.
 
That research examined antibodies against endogenous retroviruses and their potential relationship to lung cancer responses to immunotherapy. The earlier investigation attributed the misconduct to Ng.
 
Following those findings, the Francis Crick Institute expanded its examination of research associated with the former doctoral student.
 
The institute subsequently identified the problems affecting the COVID-19 vaccine publication.
 
Importantly, the institute stated that it found no evidence of malpractice involving the other authors of the vaccine paper.
 
It also reported finding no additional evidence of fabrication or inappropriate manipulation beyond the identified publications within the scope of its investigation.
 
Ng later worked as a postdoctoral researcher at Rockefeller University in New York, although university representatives confirmed that he was no longer employed there.
 
Another Scientific Publication Faces Scrutiny
Questions surrounding Ng's research activities have extended beyond the two confirmed retractions.
 
On September 29, 2026, Nature issued an editor's note concerning another paper associated with Ng after commenters on the scientific discussion platform PubPeer identified unusual numerical patterns and apparent reuse of data.
 
The journal indicated that it was investigating the concerns and would consider further editorial action when its review was completed.
 
An editor's note is not equivalent to a retraction, and the concerns regarding that additional publication should not be interpreted as established misconduct.

The case nevertheless illustrates how scrutiny of one publication can prompt closer examination of other research involving the same scientist.
 
International Researchers Cited the Questionable Findings
The retracted vaccine study had already circulated widely throughout the international scientific community.
 
Reports indicated that researchers from China, the United States, Australia, Britain, Germany, France, Belgium, Singapore, India, and Uganda had cited the publication.
 
Eight citing papers reportedly appeared during 2026 alone. Citations do not necessarily indicate that subsequent researchers accepted every experimental claim. Nevertheless, the paper's international reach demonstrates how potentially unreliable findings can enter scientific discussions and influence future research priorities.
 
Researchers who relied substantially on the retracted experiments may now need to reassess their interpretations.
 
The situation also emphasizes the importance of maintaining accessible original datasets, laboratory records, and experimental materials.
 
Without these resources, investigators cannot reliably reconstruct disputed experiments or establish whether published findings accurately represent the underlying observations.
 
Existing COVID Vaccines Are Not Invalidated
Medical experts have emphasized that this retraction does not undermine the evidence supporting currently approved COVID-19 vaccines.
 
The withdrawn research involved an experimental vaccine strategy evaluated in mice.
 
It was not the foundation for regulatory approval of existing COVID-19 vaccines.
Authorized vaccines were evaluated through extensive clinical trials and subsequent independent studies involving human populations.
 
Molecular virologist Vinod Balasubramaniam of Monash University Malaysia also emphasized that retracting one flawed publication does not invalidate the broader scientific rationale for investigating conserved coronavirus proteins.
Independent research into S2-directed immunity therefore remains scientifically relevant.
 
What This Scandal Means for Future Vaccine Research
The controversy illustrates how fabricated experimental evidence can undermine confidence in otherwise legitimate scientific investigations.
 
It also demonstrates why independent replication, transparent data management, and rigorous editorial oversight remain essential in biomedical research.
 
The withdrawal of this particular publication represents a significant setback for researchers who considered its findings promising, but it does not establish that S2-targeted vaccines are ineffective or that broader coronavirus protection is unattainable.
 
Future studies must independently establish whether S2-focused vaccine designs can generate sufficiently potent, durable, and broadly protective immune responses. The central lesson is that promising biological theories require trustworthy experimental evidence before they can support medical advances.
 
References:
https://www.science.org/doi/10.1126/scitranslmed.aem5154
 
https://www.science.org/doi/10.1126/scitranslmed.abn3715
 
https://www.nature.com/articles/s41586-026-10104-7
 
https://www.nature.com/articles/s41586-022-04888-7

MOST READ

Nov 08, 2026  14 days ago
Nikhil Prasad
Nov 04, 2026  18 days ago
Nikhil Prasad
Oct 07, 2026  2 months ago
Nikhil Prasad
Oct 05, 2026  2 months ago
Nikhil Prasad
Oct 02, 2026  2 months ago
Nikhil Prasad
Sep 22, 2026  2 months ago
Nikhil Prasad
Sep 18, 2026  2 months ago
Nikhil Prasad